Enhancing pre-clinical research with simplified intestinal cell line models.

Area of Science:

• Pharmacology
• Biotechnology
• Cell Biology

Background:

• Two-dimensional cell cultures are standard for oral drug bioavailability but lack in vivo relevance.
• Caco-2 Transwell® models are reproducible and cost-effective but have limited cellular complexity and missing transporters.
• Primary organoid models offer improved similarity but are complex, time-consuming, and expensive to establish.

Purpose of the Study:

• To develop a standardized, cost-efficient in vitro intestinal model for improved drug bioavailability assessment.
• To overcome limitations of current cell culture models for preclinical drug development.
• To establish immortalized intestinal cell lines from primary organoids.

Main Methods:

• Immortalization of primary organoid-derived intestinal cells.
• Establishment of Transwell®-like models using the immortalized cell lines.
• Characterization of barrier integrity, ultrastructural features, and transport functions.

Main Results:

• Successfully established immortalized intestinal cell lines retaining organoid cellular diversity.
• Developed cost-efficient and standardized cell line-based Transwell®-like models.
• Demonstrated organ-specific epithelial barrier integrity, ultrastructural features, and representative transport functions.

Conclusions:

• Novel immortalized organoid-derived cell lines provide a cost-efficient and standardized in vitro model.
• These models closely mimic in vivo intestinal conditions for preclinical drug screening.
• The developed models are suitable for enhanced bioavailability studies and patient risk assessment.